Tilray Brands (NASDAQ:TLRY) Shares Down 2.6% – What’s Next?

Tilray Brands, Inc. (NASDAQ:TLRY)’s stock price dropped 2.6% during trading on Tuesday . The company traded as low as $4.85 and last traded at $4.88. Approximately 3,505,275 shares changed hands during mid-day trading, a decline of 19% from the average daily volume of 4,334,543 shares. The stock had previously closed at $5.01.

Trending Headlines about Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray’s beverage brands rolled out multiple summer soccer promotions across the U.S. and Canada, including watch parties, fan events, limited-edition packaging, sweepstakes, and match-day specials for Breckenridge Brewery, BrewDog USA, 10 Barrel Brewing, Pub Beer, and Shock Top. These campaigns could support brand visibility and near-term sales during a major global sporting event. Article Title
• Positive Sentiment: Breckenridge Distillery introduced Patriotic Reserve Bourbon Whiskey, a limited-release product tied to America’s 250th anniversary and Independence Day themes, giving Tilray another brand-led revenue opportunity and marketing angle. Article Title
• Neutral Sentiment: A recent weekly cannabis-sector roundup mentioned Tilray Medical’s launch of a first German-grown premium cannabis brand, but the article also highlighted mixed performance across the sector, making the overall stock impact unclear. Article Title
• Negative Sentiment: Investor commentary published on June 15 argued that Tilray’s stock remains weak and could go lower, reinforcing concerns about the company’s longer-term share price trend and profitability. Article Title

Wall Street Analysts Forecast Growth

TLRY has been the topic of a number of research analyst reports. TD Cowen reduced their target price on Tilray Brands from $10.00 to $7.00 and set a “buy” rating on the stock in a research report on Monday, March 30th. ATB Cormark Capital Markets reduced their target price on Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 2nd. Roth Mkm upgraded Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research report on Thursday, April 2nd. Weiss Ratings downgraded Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Finally, Wall Street Zen upgraded Tilray Brands from a “sell” rating to a “hold” rating in a research report on Saturday, March 21st. Three research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $11.50.

Tilray Brands Price Performance

The company has a debt-to-equity ratio of 0.19, a current ratio of 2.79 and a quick ratio of 1.66. The stock has a 50 day moving average price of $5.91 and a two-hundred day moving average price of $7.46. The firm has a market capitalization of $569.93 million, a price-to-earnings ratio of -0.36 and a beta of 1.88.

Tilray Brands (NASDAQ:TLRY) last issued its quarterly earnings data on Wednesday, April 1st. The company reported ($0.24) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.10). Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. The firm had revenue of $206.73 million during the quarter, compared to analyst estimates of $201.35 million. During the same period in the previous year, the firm posted ($0.87) earnings per share. As a group, analysts expect that Tilray Brands, Inc. will post -0.58 EPS for the current year.

Insider Buying and Selling at Tilray Brands

In other news, Director David G. Hopkinson sold 33,556 shares of Tilray Brands stock in a transaction on Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total value of $232,878.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.84% of the company’s stock.

Institutional Investors Weigh In On Tilray Brands

A number of institutional investors have recently modified their holdings of TLRY. Hilton Head Capital Partners LLC acquired a new position in Tilray Brands during the 4th quarter worth $38,000. Essential Partners LLC boosted its stake in shares of Tilray Brands by 110,137.5% in the 1st quarter. Essential Partners LLC now owns 8,819 shares of the company’s stock valued at $57,000 after buying an additional 8,811 shares during the period. Engineers Gate Manager LP purchased a new position in shares of Tilray Brands in the 4th quarter valued at about $126,000. Oppenheimer & Co. Inc. purchased a new stake in shares of Tilray Brands during the third quarter worth approximately $25,000. Finally, R Squared Ltd purchased a new stake in shares of Tilray Brands during the first quarter worth approximately $94,000. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.